Macroeconomics: The Day Ahead for 1 Sep 2023
- US labour data and Manufacturing PMIs top busy schedule of statistics ahead of US Labor Day holiday weekend; digesting Japan Q2 CapEx, South Korea Trade, UK Nationwide House Prices; also awaiting Canada and Brazil Q2 GDP, US Auto Sales and Construction Spending
- Manufacturing PMIs: unexpected China Caixin PMI bounce, India strength offer some rays of light amid manufacturing gloom elsewhere
- US Payrolls seen posting modest but solid gain, downside risks from Hollywood strike, Yellow bankruptcy; Unemployment Rate seen unchanged; Average Hourly Earnings expected to slow m/m; labour demand ebbing, but not loose
** PLEASE NOTE: updates will be sporadic over the next month, due to conferences.
I like forward to seeing you should you be attending:
- Fastmarkets Biofuels & Feedstocks, Rotterdam – 5/6 September
- ZESTA ShipZERO workshop, London – 11 September
- Fastmarkets International Aluminium, Barcelona – 12-14 September
- Argus Methanol Forum, Houston – 19/20 September
- Energy Trading Week, London – 28/29 September
- Gulf Intelligence Energy Market Forum, Fujairah – 10/11 October
Manufacturing PMIs/ISM and the US monthly labour market report dominate a busy schedule of statistics to get the new month underway. Outside of these, there are Japan’s Q2 CapEx (expanding at a much slower rate than expected, and implying a downward revision to Q2 GDP next week), and South Korea’s Trade, Indonesian and Swiss CPI to digest, while both Brazil and Canada publish Q2 GDP, and the US also has Construction Spending and Auto Sales. In events terms SARB’s Kganyago, BoE’s Pill, Atlanta Fed’s Bostic and IMF’s Gopinath hold a panel discussion at the SARB Research Conference, and there is also some Fed speak from Mester. Next week has the US closed on Monday for the Labour day holiday, with a relatively modest run of data that includes Services PMIs, US Non-farm Productivity and Fed Beige Book, China and German Trade, German Orders and Industrial Production, UK BRC Retail Sales, Japan Wages, Household Spending and revised Q2 GDP, Australian Q2 GDP and Canadian labour data. Both the RBA and Bank of Canada are expected to hold rates, and there will be a veritable deluge of central bank speakers.
** World – Aug Manufacturing PMIs/ISM **
– Yesterday’s China NBS Manufacturing PMI at least suggested there has been no further deterioration, while the rebound in today’s Caixin measure to its best level since February (51.0 vs. expected slip to 49.0 from July 49.2) implies a potential turnaround, though it will need to be sustained to evidence some genuine traction and a boost from the piecemeal support moves for the economy and the property sector specifically. The question elsewhere is how other non-G7 Manufacturing (and the week after Services) PMIs fare relative to the broad weakness seen last week in the Eurozone, UK and US readings. The US Manufacturing ISM is expected to edge up, but at 47.0 vs. July’s 46.4, and with prices paid a key driver (forecast 44.0 vs. 42.6), this would hardly signal a turnaround for the sector.
** U.S.A. – August labour data, Auto Sales **
– The final piece of this week’s labour data jigsaw puzzle is on hand, with the renewed surge in Challenger Job Cuts adding to the looser demand profile suggested by JOLTS Job Openings and Consumer Confidence Labour Differential, notwithstanding Jobless Claims remaining low on any historical comparison. Payrolls are forecast at a slightly lower 170K (vs. 187K) and Private Payrolls seen at 145K (vs. 172K), and follow the provisional downward annual of revision 306K, with the Unemployment Rate expected to be unchanged at 3.5%. The Hollywood strike and the Yellow’s bankruptcy are expected to be a key drag on Payrolls, per se warranting some caution on interpreting any weaker than expected outturn. But the focus will be on Average Hourly Earnings, with the m/m rate seen easing to 0.3%, and y/y to 4.3%, and leaving the 3-mth annualized rate unchanged at 4.4%. If in line with forecasts, it would point to still solid labour demand, though not one which either helps or hinders the Fed’s inflation fight. Auto Sales are forecast to slip to 15.5 Mln SAAR from 15.74 Mln, well below pre-pandemic levels, but still supported by pent-up demand due to low pandemic era output, despite the rise in financing rates.
To view the full report and to sign up for daily market commentary please email firstname.lastname@example.org
Risk Warning: Investments in Equities, Contracts for Difference (CFDs) in any instrument, Futures, Options, Derivatives and Foreign Exchange can fluctuate in value. Investors should therefore be aware that they may not realise the initial amount invested and may incur additional liabilities. These investments may be subject to above average financial risk of loss. Investors should consider their financial circumstances, investment experience and if it is appropriate to invest. If necessary, seek independent financial advice.
ADM Investor Services International Limited, registered in England No. 2547805, is authorised and regulated by the Financial Conduct Authority [FRN 148474] and is a member of the London Stock Exchange. Registered office: 3rd Floor, The Minster Building, 21 Mincing Lane, London EC3R 7AG.
A subsidiary of Archer Daniels Midland Company.
© 2021 ADM Investor Services International Limited.
Futures and options trading involve significant risk of loss and may not be suitable for everyone. Therefore, carefully consider whether such trading is suitable for you in light of your financial condition. The information and comments contained herein is provided by ADMIS and in no way should be construed to be information provided by ADM. The author of this report did not have a financial interest in any of the contracts discussed in this report at the time the report was prepared. The information provided is designed to assist in your analysis and evaluation of the futures and options markets. However, any decisions you may make to buy, sell or hold a futures or options position on such research are entirely your own and not in any way deemed to be endorsed by or attributed to ADMIS. Copyright ADM Investor Services, Inc.